1255 related articles for article (PubMed ID: 15965076)
21. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis.
Naini A; Mehrazin M; Lu J; Gordon P; Mitsumoto H
J Neurol Sci; 2007 Mar; 254(1-2):17-21. PubMed ID: 17257622
[TBL] [Abstract][Full Text] [Related]
23. Denaturational stress induces formation of zinc-deficient monomers of Cu,Zn superoxide dismutase: implications for pathogenesis in amyotrophic lateral sclerosis.
Mulligan VK; Kerman A; Ho S; Chakrabartty A
J Mol Biol; 2008 Nov; 383(2):424-36. PubMed ID: 18761352
[TBL] [Abstract][Full Text] [Related]
24. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
Gomes C; Keller S; Altevogt P; Costa J
Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
[TBL] [Abstract][Full Text] [Related]
25. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
[TBL] [Abstract][Full Text] [Related]
26. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
27. Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis.
Sala G; Beretta S; Ceresa C; Mattavelli L; Zoia C; Tremolizzo L; Ferri A; Carrì MT; Ferrarese C
Neurochem Int; 2005 Feb; 46(3):227-34. PubMed ID: 15670639
[TBL] [Abstract][Full Text] [Related]
28. In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult.
Eum WS; Kim DW; Hwang IK; Yoo KY; Kang TC; Jang SH; Choi HS; Choi SH; Kim YH; Kim SY; Kwon HY; Kang JH; Kwon OS; Cho SW; Lee KS; Park J; Won MH; Choi SY
Free Radic Biol Med; 2004 Nov; 37(10):1656-69. PubMed ID: 15477017
[TBL] [Abstract][Full Text] [Related]
29. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.
Kruman II; Pedersen WA; Springer JE; Mattson MP
Exp Neurol; 1999 Nov; 160(1):28-39. PubMed ID: 10630188
[TBL] [Abstract][Full Text] [Related]
30. Unfolding and folding kinetics of amyotrophic lateral sclerosis-associated mutant Cu,Zn superoxide dismutases.
Rumfeldt JA; Lepock JR; Meiering EM
J Mol Biol; 2009 Jan; 385(1):278-98. PubMed ID: 18951903
[TBL] [Abstract][Full Text] [Related]
31. 9-polylysine protein transduction domain: enhanced penetration efficiency of superoxide dismutase into mammalian cells and skin.
Park J; Ryu J; Jin LH; Bahn JH; Kim JA; Yoon CS; Kim DW; Han KH; Eum WS; Kwon HY; Kang TC; Won MH; Kang JH; Cho SW; Choi SY
Mol Cells; 2002 Apr; 13(2):202-8. PubMed ID: 12018841
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of metallothionein protects cultured motor neurons against oxidative stress, but not mutant Cu/Zn-superoxide dismutase toxicity.
Taylor DM; Minotti S; Agar JN; Durham HD
Neurotoxicology; 2004 Sep; 25(5):779-92. PubMed ID: 15288509
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K
J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336
[TBL] [Abstract][Full Text] [Related]
34. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
Aoki M
Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
[TBL] [Abstract][Full Text] [Related]
35. The ALS-associated mutation G93A in human copper-zinc superoxide dismutase selectively destabilizes the remote metal binding region.
Museth AK; Brorsson AC; Lundqvist M; Tibell LA; Jonsson BH
Biochemistry; 2009 Sep; 48(37):8817-29. PubMed ID: 19655787
[TBL] [Abstract][Full Text] [Related]
36. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
Gonzalez de Aguilar JL; Dupuis L; Oudart H; Loeffler JP
Biomed Pharmacother; 2005 May; 59(4):190-6. PubMed ID: 15862714
[TBL] [Abstract][Full Text] [Related]
37. Interplay of Cu,Zn superoxide dismutase and nitric oxide synthase in neurodegenerative processes.
Rotilio G; Aquilano K; Ciriolo MR
IUBMB Life; 2003; 55(10-11):629-34. PubMed ID: 14711010
[TBL] [Abstract][Full Text] [Related]
38. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.
Rosen DR; Siddique T; Patterson D; Figlewicz DA; Sapp P; Hentati A; Donaldson D; Goto J; O'Regan JP; Deng HX
Nature; 1993 Mar; 362(6415):59-62. PubMed ID: 8446170
[TBL] [Abstract][Full Text] [Related]
39. Dominant role of copper in the kinetic stability of Cu/Zn superoxide dismutase.
Lynch SM; Colón W
Biochem Biophys Res Commun; 2006 Feb; 340(2):457-61. PubMed ID: 16375856
[TBL] [Abstract][Full Text] [Related]
40. Familial amyotrophic lateral sclerosis.
Siddique T; Hentati A
Clin Neurosci; 1995-1996; 3(6):338-47. PubMed ID: 9021255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
